Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

1.

In Vivo Tumor Vasculature Targeted PET/NIRF Imaging with TRC105(Fab)-Conjugated, Dual-Labeled Mesoporous Silica Nanoparticles.

Chen F, Nayak TR, Goel S, Valdovinos HF, Hong H, Theuer CP, Barnhart TE, Cai W.

Mol Pharm. 2014 Jun 25. [Epub ahead of print]

PMID:
24937108
[PubMed - as supplied by publisher]
2.

Engineering of hollow mesoporous silica nanoparticles for remarkably enhanced tumor active targeting efficacy.

Chen F, Hong H, Shi S, Goel S, Valdovinos HF, Hernandez R, Theuer CP, Barnhart TE, Cai W.

Sci Rep. 2014 May 30;4:5080. doi: 10.1038/srep05080.

PMID:
24875656
[PubMed - in process]
Free PMC Article
3.

Endoglin for targeted cancer treatment.

Rosen LS, Gordon MS, Robert F, Matei DE.

Curr Oncol Rep. 2014 Feb;16(2):365. doi: 10.1007/s11912-013-0365-x.

PMID:
24445497
[PubMed - in process]
4.

Tumor vasculature targeting and imaging in living mice with reduced graphene oxide.

Shi S, Yang K, Hong H, Valdovinos HF, Nayak TR, Zhang Y, Theuer CP, Barnhart TE, Liu Z, Cai W.

Biomaterials. 2013 Apr;34(12):3002-9. doi: 10.1016/j.biomaterials.2013.01.047. Epub 2013 Jan 29.

PMID:
23374706
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Positron emission tomography imaging of tumor angiogenesis with a (61/64)Cu-labeled F(ab')(2) antibody fragment.

Hong H, Zhang Y, Orbay H, Valdovinos HF, Nayak TR, Bean J, Theuer CP, Barnhart TE, Cai W.

Mol Pharm. 2013 Feb 4;10(2):709-16. doi: 10.1021/mp300507r. Epub 2013 Jan 14.

PMID:
23316869
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Endoglin requirement for BMP9 signaling in endothelial cells reveals new mechanism of action for selective anti-endoglin antibodies.

Nolan-Stevaux O, Zhong W, Culp S, Shaffer K, Hoover J, Wickramasinghe D, Ruefli-Brasse A.

PLoS One. 2012;7(12):e50920. doi: 10.1371/journal.pone.0050920. Epub 2012 Dec 27.

PMID:
23300529
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene.

Hong H, Yang K, Zhang Y, Engle JW, Feng L, Yang Y, Nayak TR, Goel S, Bean J, Theuer CP, Barnhart TE, Liu Z, Cai W.

ACS Nano. 2012 Mar 27;6(3):2361-70. doi: 10.1021/nn204625e. Epub 2012 Feb 16.

PMID:
22339280
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Endoglin-targeted cancer therapy.

Seon BK, Haba A, Matsuno F, Takahashi N, Tsujie M, She X, Harada N, Uneda S, Tsujie T, Toi H, Tsai H, Haruta Y.

Curr Drug Deliv. 2011 Jan;8(1):135-43. Review.

PMID:
21034418
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk